| 赵蕴华,袁 芳.世界主要国家（地区）细胞免疫政策分析[J].全球科技经济瞭望,2018,(2):69~76 |
| 世界主要国家（地区）细胞免疫政策分析 |
| Cellular Immunotherapy Policies in Major Countries and Regions |
| 投稿时间：2018-01-14 |
| DOI：10.3772/j.issn.1009-8623.2018.02.011 |
| 中文关键词: 细胞免疫；技术发展；政策监管 |
| 英文关键词: cellular immunotherapy; technology development; policies supervision |
| 基金项目:中国科协重大科技前沿和创新战略跟踪研究“分项研究-新能源领域前沿跟踪研究”（Y701641901）。 |
|
| 摘要点击次数: 2168 |
| 全文下载次数: 2212 |
| 中文摘要: |
| 发展迅速的细胞免疫治疗被认为是第4种治疗癌症的方法，临床应用前景广阔。鉴于细胞免疫技术的特殊性，其政策监管需要根据其独有的技术特点单独制定。本文首先分析了细胞免疫技术的发展现状，然后通过对世界主要国家与地区的细胞免疫政策监管的探讨，结合中国的实际情况，为中国细胞免疫的发展提出建议。 |
| 英文摘要: |
| Cellular immunotherapy is considered to be the fourth method for treating cancer. Cellular immunotherapy technology is rapidly developing and possesses broad clinical applications. In view of the special nature, the regulatory policies of cellular immunotherapy technology need to be separately formulated according to its unique technical characteristics. Therefore, this paper firstly analyzes the development status of cellular immunotherapy technology. Then, based on the discussion about policies of cellular immunotherapy in major countries and regions in the world and China’s actual conditions, suggestions are provided for the development of cellular immunotherapy in China. |
|
查看全文
查看/发表评论 下载PDF阅读器 |
| 关闭 |
